Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases GRC 2027: Bridging the Gap between Foundational Science and Effective Therapy

Sessions cover ageing and other risk modifiers; lysosomal links to disease; mechanisms of propagation; RNA granules and metabolism; novel themes in motor neuron disease; muscle contributions; glia and immunity; the translation of biology into biomarkers; and therapeutic approaches to motor neuron disease. The programme reserves time for discussion after each talk, poster sessions open to all career stages and informal exchange; an associated Gordon Research Seminar for early-career scientists runs in conjunction and needs its own application.